Method for preparing ilomastat

A technology for ilomastat and intermediates, which is applied in the field of preparation of ilomastat, can solve the problems of cumbersome operation and dark product color, and achieve the effects of increasing solubility, high condensation efficiency, and not easy to deliquescence

Inactive Publication Date: 2010-02-24
INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Experiments have found that when trifluoroacetic acid is used to remove tert-butyl ester, it may be due to the indole group in the structure, resulting in a darker color of the product, and in the post-treat

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing ilomastat
  • Method for preparing ilomastat
  • Method for preparing ilomastat

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0044] The present invention will be further illustrated by specific preparation examples below, however, it should be understood that these examples are only used for more detailed description and should not be construed as limiting the present invention in any form. In the description of the present invention, unless otherwise specified, the reagents, raw materials, intermediates, solvents, etc. used can be obtained from commercial sources or prepared by methods known to those skilled in the art.

[0045] 1, Preparation of L-Tryptophanamide (II)

[0046] Mix L-tryptophan methyl ester hydrochloride (144.74g, 0.57mol) with methylamine aqueous solution (25-30%) 430mL, stir at room temperature for 7 hours, use dichloromethane to carry out continuous extraction for 5 hours, separate , the obtained organic phase was dried with anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure to obtain a light yellow solid, which was washed with P 2 o 5 After dr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a new method for preparing ilomastat, which comprises the following steps of: reacting a tryptophan methyl ester hydrochloride with a methylamine to prepare tryptophanyl methylamine; performing a condensation reaction between the tryptophanyl methylamine and a tert-butyl acetate succinate derivative to prepare a midbody of a formula (IV); removing the tert-butyl from the midbody of formula (IV) to form a midbody of a formula (V); and performing a condensation reaction between the midbody of formula (V) and a free hydroxylamine to form the ilomastat. The method of the invention is simple in the process and low in the cost.

Description

technical field [0001] The present invention relates to a new method for preparing ilomastat. Background technique [0002] Ilomastat (English name: Ilomastat, chemical name: N-[(2R)-2-(hydroxylaminecarbonylmethyl)-4-methylpentanylcarbonyl]-L-tryptophanamide), is a Broad-spectrum, potent matrix metalloproteinase inhibitor, which has a strong inhibitory effect on multiple members of the matrix metalloproteinase family. The chemical structural formula of ilomastat is as follows: [0003] [0004] In the 1990s, the American company Glycomed first developed it for the treatment of corneal ulcers. Clinical trials have shown that ilomastat has a good therapeutic effect on alkali-induced corneal damage. In recent years, it has been found that ilomastat has the effect of slowing down and improving facial wrinkles and preventing myopia. [0005] WO 9209563 discloses a method for preparing ilomastat as shown in the following scheme: [0006] [0007] The method disclosed in ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D209/20
Inventor 刘克良韩寒梁远军许笑宇
Owner INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap